Mango-flavored pill shows promise in treating intestinal worms in children

A new mango-flavored pill combining two anti-parasitic drugs has shown promise in trials for treating intestinal worms, which affect about 1.5 billion people worldwide. This combination may be more effective and help prevent drug resistance. The pill was tested in a clinical trial with 1,001 children in Ethiopia, Kenya, and Mozambique. Results indicated improved effectiveness against various infections when used with ivermectin, although its impact on threadworm remains unclear. The trial results have been submitted to regulators in Europe and Africa, with decisions expected in early 2025. A larger trial involving 20,000 participants is being planned in Kenya and Ghana.